Compile Data Set for Download or QSAR
Report error Found 3238 Enz. Inhib. hit(s) with Target = 'Cathepsin K'
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19814(benzyl N-[(1S)-3-methyl-1-{[(3S)-5-methyl-2-oxo-1-...)
Affinity DatapH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19736(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-[2-(4-meth...)
Affinity DataIC50: 0.00300nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19737(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-[2-(3-meth...)
Affinity DataIC50: 0.00300nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19743(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-(2-{4-[2-(...)
Affinity DataIC50: 0.00300nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19744(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-(2-{3-[2-(...)
Affinity DataIC50: 0.00300nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19518(CHEMBL195454 | (2S)-N-(cyanomethyl)-4-methyl-2-{[(...)
Affinity DataIC50: 0.00500nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19733(2-cyano-4-(cyclohexylamino)-N-[2-(3-methoxyphenyl)...)
Affinity DataIC50: 0.00900nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19731(2-cyano-4-(cyclohexylamino)-N-(2-phenylethyl)pyrim...)
Affinity DataIC50: 0.0100nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19740(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-{2-[3-(4-m...)
Affinity DataIC50: 0.0110nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19741(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-(2-{4-[(4-...)
Affinity DataIC50: 0.0110nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19742(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-(2-{4-[(1-...)
Affinity DataIC50: 0.0130nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50251429(4'-Piperazin-1-yl-biphenyl-4-carboxylic acid [(S)-...)
Affinity DataIC50: 0.0150nMAssay Description:Inhibition of cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19732(2-cyano-4-(cyclohexylamino)-N-[2-(4-methoxyphenyl)...)
Affinity DataIC50: 0.0220nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19739(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-{2-[4-(4-m...)
Affinity DataIC50: 0.0250nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50169493((S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-...)
Affinity DataIC50: 0.0251nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50169495([(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbam...)
Affinity DataIC50: 0.0257nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50169482([(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbam...)
Affinity DataIC50: 0.0288nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19745(2-cyano-4-[(2,2-dimethylpropyl)amino]-N-(2-{3-[2-(...)
Affinity DataIC50: 0.0310nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19735(2-cyano-4-(cyclohexylamino)-N-{2-[4-(4-methylpiper...)
Affinity DataIC50: 0.0470nMpH: 7.0 T: 2°CAssay Description:The substrate hydrolysis with or without inhibitor was monitored at an excitation wavelength of 360nm and an emission wavelength of 460 nm on a fluor...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50163831((2S)-1-cyclohexylpropan-2-yl 1-cyanoazetidine-2-ca...)
Affinity DataIC50: 0.0480nMAssay Description:Inhibitory concentration against human cathepsin K using 10 uM Cbz-Phe-Arg-AMCMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19783((2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]...)
Affinity DataIC50: 0.0720nMpH: 5.5 T: 2°CAssay Description:Assays were carried out in the presence of variable concentrations of test compound. Reactions were initiated by addition of enzyme to buffered solut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19783((2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]...)
Affinity DataIC50: 0.0724nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19524((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.100nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19530((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.100nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19908((1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{2-methyl-4...)
Affinity DataIC50: 0.100nM EC50:  17nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50084655([(S)-1-((S)-1-Formyl-pentylcarbamoyl)-3-methyl-but...)
Affinity DataIC50: 0.110nMAssay Description:Inhibitory activity against recombinant human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50084655([(S)-1-((S)-1-Formyl-pentylcarbamoyl)-3-methyl-but...)
Affinity DataIC50: 0.110nMAssay Description:Inhibitory activity against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50461260(CHEMBL4228926)
Affinity DataIC50: 0.110nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50169488((1R)-2,2-DIMETHYL-1-({5-[4-(TRIFLUOROMETHYL)PHENYL...)
Affinity DataIC50: 0.129nMAssay Description:Inhibition of human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50148310(((S)-1-Formyl-pentyl)-carbamic acid (S)-1-benzyl-p...)
Affinity DataIC50: 0.130nMAssay Description:Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 uM Cbz-Phe-Arg-AMC as substrateMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50148310(((S)-1-Formyl-pentyl)-carbamic acid (S)-1-benzyl-p...)
Affinity DataIC50: 0.130nMAssay Description:Inhibitory concentration against human cathepsin K using 10 uM Cbz-Phe-Arg-AMCMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50255925(N-((S)-4-fluoro-4-methyl-1-oxo-1-((S)-3-oxo-1-(pyr...)
Affinity DataIC50: 0.160nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19489((2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19523((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19532((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19489((2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19533((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19538((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19544((2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Rabbit)
Merck Frosst Centre For Therapeutic Research

LigandPNGBDBM19908((1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{2-methyl-4...)
Affinity DataIC50: 0.200nM EC50:  17nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50150528((S)-4-Methyl-2-[4-(4-piperazin-1-yl-phenyl)-thioph...)
Affinity DataIC50: 0.200nMAssay Description:Inhibitory concentration against human cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50214543((S)-4-methyl-2-[(S)-2,2,2-trifluoro-1-(4'-methanes...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19489((2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM19489((2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifl...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50255753(MK-0822 | Odanacatib | CHEMBL481611)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50306304((S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-((S...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50306306((S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-((S...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50306307((S)-2-((S)-1-(4'-((S)-1-amino-1-oxopropan-2-yl)bip...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50306309(1-(4'-((S)-1-((S)-1-(1-cyanocyclopropylamino)-4-fl...)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin K(Human)
Gsk

LigandPNGBDBM50255753(MK-0822 | Odanacatib | CHEMBL481611)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of humanized rabbit cathepsin KMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 3238 total ) | Next | Last >>
Jump to: